Safety and Efficacy of Ondansetron and Simvastatin as Potential Adjunctive Treatment for Patients With Schizophrenia: A Systematic Review of Randomized Controlled Trials.

Cureus · 2023 · PMC10349656 · PMID 37456496

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

marginal significancep=0.06so close (0.05 < p ≤ 0.1)

Ondansetron usage showed marginal significance in the total PANSS (p=0.06) by week 12, with the cognitive subscale showing marked improvement (p<0.05) [ 29 ].

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.